🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of sitravat...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-30
Trial ID
NCT05564338
Treatments Being Tested
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
This study was designed to compare the efficacy and safety of tislelizumab ...
Status
Completed
Location
University of California Davis Health System
Start Date
2018-12-13
Trial ID
NCT03777657
Treatments Being Tested
The primary objective of this study is to evaluate and compare major pathol...
Status
Active Not Recruiting
Location
Anhui Provincial Hospital
Start Date
2020-05-29
Trial ID
NCT04379635
Treatments Being Tested
This is a phase 3, randomized, double-blind, placebo-controlled study to co...
Status
Completed
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2019-06-11
Trial ID
NCT03957590
Treatments Being Tested
This study was designed to compare the efficacy and safety of tislelizumab ...
Status
Completed
Location
Anhui Provincial Hospital
Start Date
2019-03-27
Trial ID
NCT03924986
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of tisleli...
Status
Completed
Location
Smilow Cancer Hospital At Yale
Start Date
2018-12-11
Trial ID
NCT03783442
Treatments Being Tested
This study aimed to evaluate the safety and effectiveness of ociperlimab co...
Status
Completed
Location
Valkyrie Clinical Trials
Start Date
2021-11-16
Trial ID
NCT05014815
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, Phase ...
Status
Active Not Recruiting
Location
Anhui Provincial Hospital
Start Date
2019-05-29
Trial ID
NCT03967977
Treatments Being Tested